Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.53% | 35.14% | 51.04% | 102.38% | 36.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.53% | 35.14% | 51.04% | 102.38% | 36.33% |
| Cost of Revenue | -6.68% | 2.79% | -3.03% | 2.44% | -5.68% |
| Gross Profit | 92.49% | 153.47% | 409.39% | 830.37% | 1,231.49% |
| SG&A Expenses | 15.05% | 17.02% | 11.12% | 9.57% | 8.24% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.23% | 0.00% | -0.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.06% | 9.79% | 3.88% | 5.84% | 0.73% |
| Operating Income | 37.01% | 35.12% | 62.25% | 131.53% | 37.59% |
| Income Before Tax | -56.06% | 32.90% | 59.73% | 129.74% | 44.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.06% | 32.90% | 59.73% | 129.74% | 44.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 828.57% | 18.18% | -100.00% | -96.15% | -180.77% |
| Net Income | -55.34% | 32.89% | 59.70% | 129.77% | 44.58% |
| EBIT | 37.01% | 35.12% | 62.25% | 131.53% | 37.59% |
| EBITDA | 41.20% | 38.21% | 70.81% | 152.41% | 41.52% |
| EPS Basic | -47.80% | 35.63% | 61.11% | 128.79% | 46.30% |
| Normalized Basic EPS | 40.74% | 37.18% | 61.94% | 128.79% | 36.34% |
| EPS Diluted | -47.80% | 35.63% | 59.58% | 127.27% | 46.30% |
| Normalized Diluted EPS | 40.74% | 37.18% | 61.94% | 126.95% | 36.34% |
| Average Basic Shares Outstanding | 5.11% | 4.24% | 3.69% | 3.33% | 3.17% |
| Average Diluted Shares Outstanding | 5.11% | 4.24% | 3.69% | 10.61% | 3.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |